Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Metals & Mining
Considering the uncertainty surrounding COVID-19 (and Gemfields’ inability to hold emerald and ruby auctions while international travel is severely restricted), we have considered three COVID-19 scenarios in terms of recovery timing. In both our faster recovery and central case scenarios, Gemfields remains EBITDA positive in 2020 and ends the year in a net cash position.
Written by
Gemfields Group |
Still good value under varied COVID-19 scenarios |
COVID-19 update |
Metals & mining |
28 April 2020 |
Share price performance
Business description
Next events
Analyst
Gemfields Group is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||
Considering the uncertainty surrounding COVID-19 (and Gemfields’ inability to hold emerald and ruby auctions while international travel is severely restricted), we have considered three COVID-19 scenarios in terms of recovery timing. In both our faster recovery and central case scenarios, Gemfields remains EBITDA positive in 2020 and ends the year in a net cash position.
Year end |
Revenue (US$m) |
PBT* |
EPS* |
DPS |
P/E |
Yield |
12/18 |
206.1 |
(22.5) |
(2.6) |
0.0 |
N/A |
N/A |
12/19 |
216.2 |
55.9 |
1.3 |
0.0 |
6.4 |
N/A |
12/20e |
101.8 |
(15.9) |
(1.4) |
0.0 |
N/A |
N/A |
12/21e |
240.5 |
58.4 |
2.0 |
0.0 |
4.2 |
N/A |
Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
Strong 2019 reflects underlying business strength
Record auction revenues saw Gemfields generate US$80.9m in EBITDA in 2019 (2018: US$58.9m), a 37% EBITDA margin despite the imposition of a 15% export tax on Zambian emeralds, which cost the group US$12.4m in 2019 (and has since been removed). Gemfields ended 2019 with cash of US$78.2m and net cash of US$25.4m (up from net cash of US$9.8m at the end of 2018).
COVID-19 scenarios suggest relative resilience
For Gemfields, the key impact of COVID-19 is the inability to hold emerald and ruby auctions while customers are unable to travel internationally. Operationally, production is currently suspended at both Kagem and Montepuez Ruby Mining (MRM). We have considered three COVID-19 scenarios, looking particularly at Gemfields’ ability to hold auctions in 2020 (but also considering longer-term sales impacts and production and cost impacts including the benefit of weaker local currencies in Zambia and Mozambique). Gemfields remains EBITDA positive this year in our faster recovery and central cases, generating 2020 EBITDA of US$26m and US$11m, respectively (previous forecast US$75m). The slower recovery scenario sees a 2020 EBITDA loss of US$14m. We see Gemfields ending 2020 with net cash of US$15m in the faster recovery scenario, net cash of US$4m in our central case and net debt of US$21m in the slower recovery scenario.
Value upside under all three COVID-19 scenarios
Our central case sum-of-the-parts DCF valuation of Gemfields sees a 12% drop in dollar terms to US$459m (from US$522m previously) with the lower value reflecting the reduction in 2020 cash flows with any 2021/22 market impact mitigated by the ability to selectively sell inventory carried over from 2020. Our faster recovery valuation is US$497m (5% below our previous valuation), but our slower scenario is US$339m (35% below our previous valuation) as this assumes a longer-term demand and thus pricing impact. When converted to rand per share terms (of interest particularly to South African investors) the negative value impact is offset by the sharply weaker rand (ZAR18.95/US$ vs ZAR14.87/US$ previously).
Strong set of 2019 full-year results
While in the context of current global uncertainties investors may be more focused on the outlook for 2020 and risks relating to nearer-term cash flows, we think it is important to look at the strength of the underlying business that is clearly evidenced in Gemfields’ solid 2019 full-year results, which were released on 6 April 2020.
Gemfields generated record revenue of US$216.2m (2018: US$206.1m) and EBITDA of US$80.9m (2018: US$58.9m), a 37% EBITDA margin (2018: 29%). Those strong results are despite the imposition of a 15% export tax on Zambian emeralds during 2019 (since removed), which reduced 2019 EBITDA by US$12.4m.
Gemfields ended 2019 with a strong balance sheet, with cash of US$78.2m and net cash of US$25.4m (up from net cash of US$9.8m at the end of 2018). Free cash flow from operations before working capital movements of US$31.1m was offset by a US$25.7m negative movement in working capital largely as a result of an increase in receivables from the large (US$71.5m) ruby auction, which only concluded on 14 December 2019. The bulk of the US$56.7m in auction receivables outstanding at 31 December 2019 were collected by the end of February 2020. The strong balance sheet position means that Gemfields begins 2020 well placed to weather the storm.
Exhibit 1: Key metrics from 2019 full-year results
2018 |
2019 |
|
Revenue (US$m) |
206.1 |
216.2 |
EBITDA (US$m) |
58.9 |
80.9 |
EBITDA margin (%) |
29% |
37% |
Normalised PBT (US$m) |
(22.5) |
55.9 |
Normalised EPS (c) |
(2.6) |
1.3 |
Closing net cash/(debt) (US$m) |
9.8 |
25.4 |
Source: Gemfields
Given the uncertainties surrounding the ability to conduct emerald and ruby auctions, which require customers to travel internationally, the 2019 results contain a note in relation to the going concern basis of accounting (note 12). Specifically, investors should be aware that if Gemfields is not able to conduct any emerald or ruby auctions by October 2020, the company may need to renegotiate existing debt facilities (covenants) and potentially seek additional funding and/or take more drastic action to reduce costs.
Three scenarios for COVID-19 impact on Gemfields
On 30 March, Gemfields announced that all but critical operations at Kagem had been suspended for at least a month. The company also announced it was likely that the emerald (high quality, HQ) and ruby (mixed quality, MQ) auctions originally scheduled for May and June 2020, respectively, are highly likely to be rescheduled, with the possibility that the subsequent emerald (HQ) and ruby (MQ) auctions originally scheduled for November and December 2020 may be cancelled altogether. And on 22 April Gemfields further announced that operation at MRM would also be suspended in response to COVID-19. The company is also increasing security at MRM in response to increased local security risks. UK staff (including directors) will take a 20% temporary cut in pay in May.
Gemfields generates more than 90% of its revenues from emerald and ruby auctions usually comprising two HQ emerald auctions (May and November, usually in Singapore), two commercial-quality (CQ) emerald auctions (February and August, usually in Lusaka) and two MQ ruby auctions (June and December, usually in Singapore). The challenge from a practical perspective is that these auctions rely on customers travelling from multiple countries to carefully inspect the stones and determine the value of their bids. This process cannot take place remotely without the customers having physical access to the stones. For Gemfields to hold auctions thus requires not only the lifting of COVID-19 lockdowns in the respective locations of the planned auctions, but also lifting worldwide travel restrictions to the extent required to allow free movement of both stones and customers between countries.
In note 12 to the company’s final 2019 results (‘going concern’) Gemfields also notes that it believes it would be prudent, even once COVID-19 restrictions are lifted, to allow customers ample time to recover before the first auctions are held. As such, Gemfields expects to hold auctions only in the fourth quarter of 2020, with one HQ emerald, one further CQ emerald and one ruby auction held in Q4 (in addition to the CQ auction already held in February 2020, which generated sales proceeds of US$11.5m).
We have looked at three potential scenarios for Gemfields in terms of the potential impact of COVID-19 on 2020 and longer-term metrics. Each scenario is described below with the key assumptions and impact on forecast key metrics compared in Exhibits 2 and 3 below.
Central case
In terms of auction sales, our central case assumes that no mid-year auctions will be held and that one CQ emerald, one HQ emerald and one ruby auction are held in Q4. We assume the Q4 auctions will be of a similar volume to what would normally have been the case but now assume prices 10% lower than our previous forecasts. While the risk to demand and pricing is on the downside given the current challenging economic conditions, we believe that the lack of May/June auctions could potentially result in at least some pent up demand from customers, which should help to partially mitigate the impact.
Operationally, our central case assumes a two-month shutdown of operations at Kagem (ie extending the one-month shutdown announced on 30 March) and a similar length shutdown at MRM.
In terms of costs, our central case sees a 15% decrease in 2020 cash mining and production costs in absolute terms relative to our previous forecasts as a result of:
■
The impact of the eight-week suspensions at Kagem and MRM on direct marginal cash costs (fuel and consumables) and some reduction in salaries during the period (we assume an average 20% labour cost saving over the two months, noting that salaries were paid in full at Kagem during April).
■
The weaker Zambian kwacha and Mozambican metical, down 9% and 31% year-to-date respectively (approximately 30–35% of cash mining and production costs are in local currency but local cost inflation must be taken into account).
■
A lower oil price (although there will be a lag time before any change in international oil prices is reflected in local fuel costs).
We also forecast a 25% decline in selling, general and admin costs relative to our previous forecasts, partly as a result of direct costs not being incurred in relation to May and June auctions and taking into account the announced 20% reduction in UK (including board) salaries for May.
From 2021 onwards, our central case sees a more limited longer-term impact on MRM and Kagem. We assume::
■
A reduction in MRM production relative to our previous forecasts, as a result in the deferral of the second washplant (but with little impact on sales, as the company should have some inventory to hand, assuming that the 2020 shutdown is not longer than two months).
■
Any continued demand weakness in the coloured gemstone market in 2021/22 will be largely offset in terms of Gemfields revenue by the company’s high levels of inventory of high-quality emerald and rubies at the end of 2020 giving Gemfields the ability to carefully manage both quantity and quality of stones presented at auction in 2021 and 2022. Nevertheless, we assume that prices achieved will be 5% lower than previously forecast for 2021 and 2% lower in 2022 (recovering by 2023).
Some 80% of Faberge’s wholesale customers are currently closed, and the impact on demand is likely to be significant. We now forecast revenue of just US$9m for Faberge in 2020 (versus US$17m previously), rising to US$20m in 2022 (from US$27m previously).
Faster recovery scenario
Our faster recovery scenario assumes there is a nearer-term change in countries’ responses to the COVID-19 pandemic in terms of re-opening their economics and lifting travel restrictions. In this scenario we assume some pent-up demand from customers sees slightly larger auctions than in our central case held either late in Q3 or early in Q4. In this scenario, 2021 and 2022 benefit from some sales of excess emerald and ruby inventory produced in 2020. While this scenario may seem unlikely to most observers, we note that the current situation whereby multiple countries prevent their residents from freely leaving their own homes would have seemed even more unlikely from the standpoint of December 2019 – a lot can change in a small space of time.
Operationally, the faster recovery largely mirrors the central case but with resumption of operations two weeks earlier and thus slightly higher costs in absolute terms.
Slower recovery scenario
Our slower recovery scenario assumes certain COVID-19 restrictions are still in place in Q4 and thus Gemfields is unable to hold standard auctions even late in the year. We assume that some sales would still be possible through more flexible mechanisms, for example holding a CQ and small HQ emerald auction in Jaipur, and selling selected parcels of rubies direct to customers in key locations. In this scenario in addition to lower volumes, we assume a 15% negative impact on 2020 prices relative to our previous forecasts.
In this scenario the company would need to renegotiate and extend debt facilities and covenants, although we think it is unlikely it would need to turn to equity markets. In this scenario we also assume the company closes both Kagem and MRM for three months and takes more drastic measures to reduce costs across the business. As a result, in this scenario we see 2020 cash mining and production costs a further 5% lower than in the central case and SG&A a further 9% lower in absolute terms.
Our slower recovery scenario also assumes the more severe global economic recession affects longer-term coloured gemstone demand and thus pricing. Despite the company’s ability to offer higher-quality stones for sale from inventory built in 2020, we nevertheless reduce forecast 2021 and longer-term prices by 10% from our previous forecasts and assume 10% lower 2021 auctions sales volumes.
Overview of the three scenarios
Exhibit 2 below provides an overview of the three COVID-19 scenarios and the changes relative to our previous forecast assumptions.
Exhibit 2: Overview of Covid-19 scenarios
|
Previous forecasts |
Faster recovery |
Central case |
Slower recovery |
Auctions held remainder of 2020 |
■ One CQ emerald auction ■ Two HQ emerald auctions ■ Two MQ ruby auctions |
■ One CQ emerald auction ■ One larger HQ emerald auction ■ One larger MQ ruby auction ■ No change in price assumptions relative to previous forecast (pent up demand following no half year auctions) |
■ One CQ emerald auction ■ One HQ emerald auction ■ One mixed-quality ruby auction ■ 10% negative price impact relative to previous forecast |
■ One smaller CQ emerald auction ■ One very small HQ emerald auction ■ Very limited ruby sales ■ 15% negative price impact relative to previous forecast |
Auction volumes and pricing 2021 |
■ Higher sales volumes partially unwind 2020 inventory, ■ No change in pricing versus our previous estimates. |
■ 2021 auction volumes assumed similar to previous forecasts albeit with some change in auction mix as the company can utilise 2020 closing inventory. Lower MRM production offset by sales from inventories ■ Market pricing impact partly offset by ability to manage quality mix using closing 2020 inventory – we assume 5% price reduction in 2021 |
■ Sales volumes 10% lower than previously forecast ■ 10% lower prices relative to our previous forecasts |
|
Longer-term impact on auction sales |
■ Further inventory sales in 2022 ■ No change in price forecasts |
■ 2% price impact in 2022. ■ No longer-term auction impact relative to our previous forecasts |
■ 10% lower prices relative to our previous forecasts |
|
Operational impact at the mines |
■ 6 week mining suspensions at Kagem and MRM |
■ Two month- operations suspensions at Kagem and MRM ■ Deferral of MRM second washplant construction to 2021 |
■ Three-month suspension of Kagem and MRM ■ Significant cost cutting ■ Deferral of MRM capital to late 2021/2022 |
|
Faberge |
■ Faberge revenue of US$17m in 2020 rising to $27m in 2022 |
■ Faberge revenue of US$9m in 2020 rising to $22m in 2022 |
■ Faberge revenue of US$9m in 2020 rising to $20m in 2022 |
■ Faberge revenue of US$8m rising to US$16m in 2022 |
Cash cost impact |
■ Cash mining and production costs 3% above the central case. ■ SG&A 6% above the central case |
■ 15% reduction in cash mining and production costs in absolute terms relative to previous forecasts results from impact of suspension (but with salaries 75-80% paid), currency and fuel cost benefits ■ 25% reduction in SG&A largely as a result of not holding May and June auctions and UK May salary cuts |
■ Further 5% reduction in cash mining and production costs relative to central case to reflect additional 1month suspension ■ Further 9% cut in SG&A relative to the central case |
Source: Edison Investment Research
Forecast key metrics in each COVID-19 scenario
Exhibit 3 on the following page sets out the key metrics for Gemfields in each of these three scenarios (and for reference also includes our previous forecasts).
We would expect Gemfields to generate US$102m in 2020 revenue in the central COVID-19 scenario (a fall of 56% of our previous 2020 revenue forecast). In the faster recovery case, we would expect 2020 revenue of US$128m, but we see revenue of just US$53m in the slower recovery case. Gemfields remains EBITDA positive in 2020 in both the faster recovery and central cases generating 2020 EBITDA of US$26m and US$11m, respectively (our previous 2020 EBITDA forecast was US$75m). That falls to a 2020 EBITDA loss of US$14m in the slower recovery scenario. In 2021 EBITDA grows strongly to US$102m in the faster recovery case, US$87m in the central case and to US$79m even in the slower recovery case. In 2022 we forecast EBITDA of US$118m, US$104m and US$81m in the faster, central and slower recovery cases, respectively.
Gemfields is fortunate to be starting 2020 in a strong balance sheet position with cash of US$78.2m and net cash of US$25.4m. The company should also benefit from a sizeable positive move in working capital in 2020 as it ended 2019 with US$56.7m in auction receivables largely relating to the December 2019 ruby auction (and with the majority of this collected by the end of February 2020). In the faster recovery scenario, Gemfields would still end 2020 with net cash of US$15m, but that reduces to US$4m net cash in the central case and to net debt of US$21m in the slower recovery case.
Exhibit 3: Forecast key metrics in different COVID-19 scenarios
Key metrics |
Previous |
Faster Recovery |
Central Case |
Slower Recovery |
Kagem HQ emerald production 2020 (kct) |
850 |
810 |
800 |
759 |
Kagem revenue 2020 (US$m) |
86 |
50 |
41 |
26 |
Kagem revenue 2021 (US$m) |
94 |
101 |
90 |
77 |
Kagem revenue 2022 (US$m) |
100 |
110 |
98 |
90 |
MRM premium ruby production 2020 (kct) |
120 |
108 |
98 |
91 |
MRM premium ruby production 2021 (kct) |
145 |
114 |
114 |
109 |
MRM revenue 2020 (US$m) |
130 |
68 |
52 |
19 |
MRM revenue 2021 (US$m) |
146 |
151 |
136 |
129 |
MRM revenue 2022 (US$m) |
157 |
168 |
154 |
138 |
Faberge revenue 2020 (US$m) |
17 |
9 |
9 |
8 |
Faberge revenue 2021 (US$m) |
22 |
15 |
15 |
12 |
Faberge revenue 2022 (US$m) |
27 |
22 |
20 |
16 |
Group revenue 2020 (US$m) |
234 |
128 |
102 |
53 |
Cash mining and production costs 2020* (US$m) |
(73) |
(66) |
(62) |
(58) |
Royalties 2020 (US$m) |
(18) |
(10) |
(8) |
(3) |
Selling general and admin (US$m) |
(65) |
(54) |
(49) |
(45) |
Change in inventory 2020 (US$m) |
(3) |
27 |
28 |
39 |
Group EBITDA 2020 (US$m) |
75 |
26 |
11 |
(14) |
PBT 2020 (US$m) |
43 |
(1) |
(16) |
(41) |
EPS 2020 (c) |
1.0 |
(0.8) |
(1.4) |
(3) |
Closing net cash (debt) US$m |
59 |
15 |
4 |
(21) |
Group revenue 2021 (US$m) |
263 |
268 |
241 |
218 |
Group EBITDA 2021 (US$m) |
102 |
102 |
87 |
79 |
PBT 2021 (US$m) |
73 |
73 |
58 |
49 |
EPS 2021 (c) |
2.8 |
2.7 |
2.0 |
2 |
Closing net cash (debt) 2021 US$m |
100 |
40 |
17 |
(15) |
Group revenue 2022 (US$m) |
284 |
299 |
273 |
244 |
Group EBITDA 2022 (US$m) |
119 |
118 |
104 |
81 |
PBT 2022 (US$m) |
96 |
91 |
76 |
54 |
EPS 2022 (c) |
4.1 |
3.3 |
2.8 |
1 |
Closing net cash (debt) 2022 – US$m |
141 |
88 |
50 |
(3) |
Source: Edison Investment Research. Note: *Cash mining and production costs plus Faberge COGS.
Valuation under three COVID-19 scenarios
As previously, we value Gemfields on a discounted cash flow sum of the parts. However, given the uncertainties surrounding the pandemic, we now present three valuation scenarios in line with our three COVID-19 scenarios.
■
In our central case, significantly lower 2020 revenues than previously forecast are partly offset by lower cash costs, which reflect lower production including two-month suspensions at Kagem and MRM and should benefit from the weaker Zambian kwacha and Mozambican metical and lower fuel prices. Beyond 2020, inventory sales help to offset partially any ongoing market weakness on auction sales in 2021 and 2022 and we thus see very limited longer-term value impact. Our COVID-19 central case sum-of-the-parts valuation of Gemfields is US$459m – a 12% decrease relative to our previous Gemfields valuation of US$522m.
■
In our faster recovery scenario, the value impact of COVID-19 is even more limited, as the revenue lost at Kagem and MRM in 2020 is partly made up through higher inventory sales in 2021, 2022 and beyond. Our faster recovery sum-of-the-parts valuation of Gemfields is US$497m.
■
In our slower recovery scenario, there is a greater long-term economic and market impact and thus a far more significant valuation impact. Our sum-of-the-parts totals US$339m in this scenario (a 35% decrease from our previous valuation). Even in this scenario we note the resultant ZAR5.50/share valuation (23p per share) is well above the current share price of ZAR1.58/share. We should note, however, that in comparison to the previous two cases, in this scenario there is significantly more uncertainty as to the potential extent of the longer-term global economic impact and thus demand erosion from COVID-19.
Rand per share valuations (of interest mostly to South African investors) benefit from the sharply weaker rand (ZAR18.95/US$ vs ZAR14.87/US$ previously) used to translate our predominantly US dollar driven valuation of Gemfields to rand per share.
Exhibit 4: Sum of the parts valuation
Previous |
Faster recovery |
Central case |
Slower recovery |
|
Kagem (75%) - US$m |
246 |
234 |
220 |
173 |
Montepuez (75%) - US$m |
357 |
335 |
321 |
271 |
Fabergé - US$m |
47 |
43 |
21 |
8 |
Sedibelo (7.45%) - US$m |
40 |
40 |
40 |
40 |
Corporate overheads - US$m |
(194) |
(180) |
(179) |
(178) |
Net cash - US$m (31 Dec 19) |
25 |
25 |
25 |
25 |
Sum of the parts valuation - US$m |
522 |
497 |
459 |
339 |
Rand per share |
6.63 |
8.05 |
7.44 |
5.50 |
Pence per share |
34 |
34 |
31 |
23 |
Source: Edison Investment Research
Exhibit 5: Financial summary (central case): Financial summary (central case)
US$'m |
2017 |
2018 |
2019 |
2020e |
2021e |
2022e |
||
31-December |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
||
INCOME STATEMENT |
||||||||
Revenue |
|
|
81.7 |
206.1 |
216.2 |
101.8 |
240.5 |
272.6 |
Cost of Sales |
(44.3) |
(123.5) |
(118.5) |
(67.6) |
(115.8) |
(126.0) |
||
Gross Profit |
37.3 |
82.5 |
97.8 |
34.3 |
124.7 |
146.6 |
||
EBITDA |
|
|
30.5 |
58.9 |
80.9 |
10.9 |
87.5 |
104.3 |
Operating Profit (before amort. and except.) |
|
|
8.3 |
28.2 |
46.1 |
(15.1) |
60.0 |
77.5 |
Fair value gains (losses) |
49.5 |
(41.9) |
14.3 |
0.0 |
0.0 |
0.0 |
||
Exceptionals |
0.0 |
(22.6) |
13.2 |
0.0 |
0.0 |
0.0 |
||
Share-based payments |
(2.7) |
(4.2) |
(1.7) |
(1.5) |
(2.0) |
(2.0) |
||
Reported operating profit |
55.1 |
(40.4) |
71.9 |
(16.6) |
58.0 |
75.5 |
||
Net Interest |
(2.0) |
(8.8) |
(4.5) |
(0.8) |
(1.7) |
(1.2) |
||
Joint ventures & associates (post tax) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Profit Before Tax (norm) |
|
|
55.8 |
(22.5) |
55.9 |
(15.9) |
58.4 |
76.3 |
Profit Before Tax (reported) |
|
|
53.1 |
(53.9) |
67.4 |
(17.4) |
56.4 |
74.3 |
Reported tax |
(7.6) |
(6.5) |
(28.2) |
0.0 |
(25.3) |
(32.0) |
||
Profit After Tax (norm) |
48.2 |
(29.0) |
27.6 |
(15.9) |
33.0 |
44.3 |
||
Profit After Tax (reported) |
45.5 |
(60.4) |
39.1 |
(17.4) |
31.0 |
42.3 |
||
Minority interests |
(7.2) |
(1.8) |
(10.8) |
(0.6) |
(9.3) |
(11.4) |
||
Discontinued operations |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Net income (normalised) |
41.0 |
(30.8) |
16.9 |
(16.5) |
23.8 |
32.9 |
||
Net income (reported) |
38.3 |
(62.2) |
28.4 |
(18.0) |
21.8 |
30.9 |
||
Average Number of Shares Outstanding (m) |
1,039 |
1,169 |
1,265 |
1,169 |
1,169 |
1,169 |
||
EPS - basic normalised (c) |
|
|
3.9 |
(2.6) |
1.3 |
(1.4) |
2.0 |
2.8 |
EPS - normalised (c) |
|
|
3.9 |
(2.6) |
1.3 |
(1.4) |
2.0 |
2.8 |
EPS - basic reported (c) |
|
|
3.7 |
(5.3) |
2.2 |
(1.5) |
1.9 |
2.6 |
Dividend per share (c) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Revenue growth (%) |
- |
152.4 |
4.9 |
(52.9) |
136.2 |
13.3 |
||
Gross Margin (%) |
45.7 |
40.1 |
45.2 |
33.6 |
51.8 |
53.8 |
||
EBITDA Margin (%) |
37.3 |
28.6 |
37.4 |
10.7 |
36.4 |
38.3 |
||
Normalised Operating Margin |
10.2 |
13.7 |
21.3 |
-14.8 |
25.0 |
28.4 |
||
BALANCE SHEET |
||||||||
Fixed Assets |
|
|
639.6 |
509.7 |
507.4 |
500.7 |
503.0 |
499.9 |
Intangible Assets |
49.3 |
52.3 |
55.2 |
55.2 |
55.2 |
55.2 |
||
Tangible Assets |
378.0 |
365.0 |
376.9 |
370.2 |
372.5 |
369.4 |
||
Investments & other |
212.2 |
92.4 |
75.3 |
75.3 |
75.3 |
75.3 |
||
Current Assets |
|
|
184.1 |
224.4 |
276.8 |
238.2 |
274.3 |
317.6 |
Stocks |
118.8 |
99.2 |
110.7 |
140.2 |
144.7 |
147.7 |
||
Debtors |
27.5 |
62.1 |
87.8 |
40.8 |
59.3 |
67.2 |
||
Cash & cash equivalents |
37.8 |
63.0 |
78.2 |
57.2 |
70.3 |
102.7 |
||
Other |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Current Liabilities |
|
|
(37.0) |
(60.6) |
(75.2) |
(45.9) |
(58.3) |
(62.5) |
Creditors |
(21.2) |
(28.2) |
(29.9) |
(18.0) |
(22.7) |
(24.9) |
||
Tax payable |
(7.0) |
(1.4) |
(17.4) |
0.0 |
(7.6) |
(9.6) |
||
Short term borrowings |
(4.2) |
(23.2) |
(24.8) |
(24.8) |
(24.8) |
(24.8) |
||
Other |
(4.6) |
(7.9) |
(3.1) |
(3.1) |
(3.1) |
(3.1) |
||
Long Term Liabilities |
|
|
(169.6) |
(123.4) |
(130.1) |
(130.1) |
(130.1) |
(130.1) |
Long term borrowings |
(59.3) |
(30.0) |
(28.0) |
(28.0) |
(28.0) |
(28.0) |
||
Other long term liabilities |
(110.3) |
(93.4) |
(102.1) |
(102.1) |
(102.1) |
(102.1) |
||
Net Assets |
|
|
617.1 |
550.1 |
578.9 |
562.8 |
588.9 |
625.0 |
Minority interests |
(78.4) |
(73.9) |
(84.7) |
(85.3) |
(87.6) |
(90.7) |
||
Shareholders' equity |
|
|
538.7 |
476.2 |
494.3 |
477.6 |
501.3 |
534.2 |
CASH FLOW |
||||||||
Op Cash Flow before WC and tax |
30.5 |
58.9 |
80.9 |
10.9 |
87.5 |
104.3 |
||
Working capital |
(9.7) |
(29.7) |
(25.7) |
(11.7) |
(10.7) |
(6.7) |
||
Exceptional & other |
0.4 |
0.3 |
(8.8) |
0.0 |
0.0 |
0.0 |
||
Tax |
(7.6) |
(24.4) |
(9.7) |
0.0 |
(25.3) |
(32.0) |
||
Net operating cash flow |
|
|
13.6 |
5.1 |
36.7 |
(0.7) |
51.5 |
65.6 |
Capex |
(11.0) |
(29.0) |
(30.8) |
(19.3) |
(29.8) |
(23.8) |
||
Acquisitions/disposals |
(17.9) |
77.4 |
35.2 |
0.0 |
0.0 |
0.0 |
||
Net interest |
(2.3) |
(4.4) |
(3.3) |
(0.8) |
(1.7) |
(1.2) |
||
Equity financing |
(0.7) |
(4.7) |
(14.4) |
(0.2) |
0.0 |
0.0 |
||
Dividends |
(5.0) |
(5.9) |
0.0 |
0.0 |
(6.9) |
(8.3) |
||
Other |
(3.4) |
(2.9) |
(7.8) |
0.0 |
0.0 |
0.0 |
||
Net Cash Flow |
(26.6) |
35.6 |
15.6 |
(21.0) |
13.1 |
32.4 |
||
Opening net debt/(cash) |
|
|
(1.2) |
25.7 |
(9.8) |
(25.4) |
(4.3) |
(17.4) |
FX |
(0.3) |
(0.1) |
0.0 |
0.0 |
0.0 |
0.0 |
||
Other non-cash movements |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Closing net debt/(cash) |
|
|
25.7 |
(9.8) |
(25.4) |
(4.3) |
(17.4) |
(49.8) |
Source: Company accounts, Edison Investment Research
|
|
The FY20 trading statement confirms underlying PBT estimates before potential further bad debts due to the COVID-19 pandemic. Trading in the core retail business is reassuring. Near term, Studio looks relatively well placed given it is trading when others are not, mark-down risk on clothing is relatively low versus competitors, its value-based offer may become more attractive as consumer incomes fall and its key trading period is towards the end of the year. We withdraw our forecasts for FY21 given the wider economic uncertainty including potentially higher bad debts.